Predictors of 30-day Mortality in ST-Elevation Myocardial Infarction (STEMI) Patients

Eka Ginanjar1, Muhammad Yamin, Ika Prasetya Wijaya

  • 1Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital. ekaginanjar@gmail.com.

Acta Medica Indonesiana
|November 9, 2019
PubMed

Insights

This study identified Killip class and glomerulus filtration rate (GFR) as key predictors of 30-day mortality in ST-elevation myocardial infarction (STEMI) patients. The developed scoring system offers a reliable tool for risk stratification.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • Assessing 30-day mortality in ST-elevation myocardial infarction (STEMI) patients is crucial for effective treatment and resource allocation.
  • Existing risk scores may not capture all relevant prognostic factors.
  • The study aimed to identify novel predictors beyond traditional TIMI scores.

Purpose of the Study:

  • To identify predictors of 30-day mortality in STEMI patients.
  • To evaluate the role of left ventricle ejection fraction (LVEF) and glomerulus filtration rate (GFR) as prognostic factors.
  • To develop and validate a new scoring system for 30-day mortality risk stratification.

Main Methods:

  • A retrospective cohort study of 487 STEMI patients hospitalized between 2004 and 2013.
  • Data analyzed using bivariate and multivariate Cox's Proportional Hazard Regression.
  • A new scoring system was developed and its calibration and discrimination assessed using Hosmer-Lemeshow test and AUC.

Main Results:

  • Killip class (II-IV) and GFR were significant predictors of 30-day mortality in STEMI.
  • The new scoring system ranged from 0 to 4.6, with scores >3.5 indicating high risk (46.5% mortality).
  • The model demonstrated satisfactory calibration and discrimination (AUC 0.816).

Conclusions:

  • Killip class and GFR are valuable predictors for 30-day mortality in STEMI patients.
  • The developed scoring system provides reliable risk stratification.
  • Further research may refine this model for clinical application.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
179
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
740
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
675
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
191
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
319
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
230